PGD2 receptor antagonists for the treatment of inflammatory diseases
US7951950B2 · kind B2 · utility
11Cited by
16References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2006 |
| Grant date | May 31, 2011 |
| Priority date | — |
| Expiry date | Jun 28, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are CRTH2 inhibitors represented by Structural Formula (I):The values for the variables of Structural Formula (I) are provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.